Publications of F. Holsboer
All genres
Journal Article (878)
721.
Journal Article
770, pp. 184 - 191 (1997)
Soluble tumor necrosis factor (p75) does not attenuate the sleep changes induced by lipopolysaccharide in the rat during the dark period. Brain Research 722.
Journal Article
27, pp. 355 - 362 (1997)
Premorbid psychometric profile of subjects at high risk for affective disorders. Psychological Medicine 723.
Journal Article
16, pp. 51 - 60 (1997)
Sleep in schizophrenia; a polysomnographic study on drug-naive patients. Neuropsychopharmacology 724.
Journal Article
17, pp. 4448 - 4460 (1997)
Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral and cytokine responses to a systemic inflammatory challenge. Journal of Neuroscience 725.
Journal Article
65, pp. 216 - 222 (1997)
Corticosteroid receptor function is decreased in depressed patients. Neuroendocrinology 726.
Journal Article
8 (1997)
Intact spatial learning and memory in transgenic mice with reduced BDNF. Neuroreport 727.
Journal Article
58, pp. 329 - 336 (1997)
Central administration of IL-1 reduces anxiety and induces sickness behaviour in rats. Pharmacology Biochemistry & Behavior 728.
Journal Article
762, pp. 12 - 18 (1997)
Behavioural performance in three substrains of mouse strain 129. Brain Research 729.
Journal Article
99, pp. 962 - 966 (1997)
Neonatal treatment of rats with the neuroactive steroid tetrahydrocorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events. Journal of Clinical Investigation 730.
Journal Article
54, pp. 89 - 90 (1997)
Smoking affects plasma soluble IL-2 receptor levels in patients with schizophrenia. Archives of General Psychiatry 731.
Journal Article
11, pp. 641 - 648 (1997)
Schlaf und Immunsystem. Schlafmodulation durch Zytokine. T & E Neurologie Psychiatrie 732.
Journal Article
175, p. 1284 - 1284 (1997)
Circadian time structure of septic shock - timing is everything - reply. Journal of Infectious Diseases 733.
Journal Article
65, pp. 189 - 199 (1997)
Increased stress-induced adrenocorticotropin response after long-term intracerebroventricular treatment of rats with antisense mineralocorticoid receptor oligodeoxynucleotides. Neuroendocrinology 734.
Journal Article
9, pp. 201 - 205 (1997)
Changes in sleep-endocrine activity after growth hormone-releasing hormone depend on time of administration. Journal of Neuroendocrinology 735.
Journal Article
331, pp. 97 - 107 (1997)
Centrally administered oligodeoxynucleotides in rats: Occurence of non-specific effects. European Journal of Pharmacology 736.
Journal Article
9, pp. 210 - 221 (1997)
Infusions of tyrosine hydroxylase antisense oligodesoxynucleotides into the substantia nigra in vivo: effects on THmRNA, TH protein content, striatal dopamine release and behavior. European Journal of Neuroscience 737.
Journal Article
72, pp. 81 - 88 (1997)
Nocturnal secretion of prolactin and cortisol and the sleep EEG in patients with major endogenous depression during an acute episode and after full remission. Psychiatry Research 738.
Journal Article
20, pp. 1038 - 1052 (1997)
Neuropeptides and human sleep. Sleep 739.
Journal Article
65, pp. 210 - 215 (1997)
Central and peripheral administration of atriopeptin is anxiolytic in rats. Neuroendocrinology 740.
Journal Article
42, pp. 882 - 888 (1997)
The effect of repeated human corticotropin-releasing hormone administration on dexamethasone-suppressed pituitary-adrenocortical activity in healthy subjects. Biological Psychiatry